Announcing a new article publication for BIO Integration journal. Pulmonary fibrosis (PF) is a progressive interstitial lung disease characterized by excessive extracellular matrix deposition and ...

A targeted antibody‑drug conjugate shrinks tumors and slows progression in recurrent uterine cancer by ferrying potent chemotherapy directly into cancer cells.

An international collaboration has developed AI-designed protein structures that self-assemble into virus-like nanocages ...

Rising Adoption of Precision Medicine, Expanding ADC Success, and Advanced Targeted Delivery Technologies Are Accelerating ...

Lymphomas, a group of heterogeneous malignancies, are among the leading causes of cancer-related mortality worldwide 1. Lymphomas account for approximately 5% of malignancies with an estimated ...

Despite recent advances in targeted drug delivery, approved Antibody-Drug-Conjugates (ADCs) are still limited by the delivery of a restricted set of payloads with limited modes of action (MOA).

Targeted drug delivery is a powerful and promising area of medicine. Therapies that pinpoint the exact areas of the body where they're needed—and nowhere they're not—can reduce the medicine dosage and ...

Targeted drug delivery has long been a cornerstone goal of modern medicine—sending therapies exactly where they’re needed while sparing healthy tissues. Yet creating treatments that can decide when ...

A research team, affiliated with UNIST has unveiled soft self-standing protein hydrogels that selectively deliver drugs, thereby enhancing medicinal effects while minimizing associated toxicity.

Researchers have demonstrated that microscopic drug delivery containers can be magnetically steered to their targets, advancing the development of precision medicine for treating diseases such as ...

Fabricated with a gel side for carrying drugs and a magnetic side for steering, these microrobots can navigate complex biological environments like intestines. Microrobots formed in droplets could ...